Knights Of Columbus Asset Advisors LLC Viking Therapeutics, Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.47 Billion
- Q4 2024
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 18,232 shares of VKTX stock, worth $530,551. This represents 0.05% of its overall portfolio holdings.
Number of Shares
18,232
Previous 18,184
0.26%
Holding current value
$530,551
Previous $1.15 Million
36.32%
% of portfolio
0.05%
Previous 0.08%
Shares
7 transactions
Others Institutions Holding VKTX
# of Institutions
467Shares Held
65.8MCall Options Held
5.84MPut Options Held
3.76M-
Vanguard Group Inc Valley Forge, PA10.2MShares$296 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$175 Million0.01% of portfolio
-
State Street Corp Boston, MA4.93MShares$143 Million0.01% of portfolio
-
Morgan Stanley New York, NY2.59MShares$75.5 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.16MShares$62.8 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $2.23B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...